Literature DB >> 8981556

Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and non-linear least squares methods.

G Wu1, P Cossettini, M Furlanut.   

Abstract

The blood cyclosporine (CsA) concentration-time profile in each of 24 adult haematological patients with multidrug resistance taking the first course of CsA treatment was fitted by one-, two- and three-compartment models to obtain relevant pharmacokinetic parameters. The pharmacokinetic parameters obtained were implemented into the PKS program (Abbottbase Pharmacokinetic System) as the population pharmacokinetic parameters used to predict blood CsA concentrations in adult haematological patients with multidrug resistance. The predictions of blood CsA concentrations by one-, two- and three-compartment models using the Bayesian method (BM) and the non-linear least squares method (NLLSM) were evaluated employing 11 patients who took the second course of CsA treatment. While the Akaike's information criterion (AIC) favoured the two-compartment model to describe CsA concentration-time profiles in patients taking the first and second courses of CsA treatment, the predictive performance analyses showed that both two- and three-compartment models were better than the one-compartment model for prediction, but the three-compartment model was slightly superior to the two-compartment model. The results also show that the predictions using BM were slightly better than those using NLLSM. Several factors affecting BM predictions and the possible difference among AIC, BM and predictive performance analyses were also addressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981556     DOI: 10.1006/phrs.1996.0063

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.

Authors:  Hélène Bourgoin; Gilles Paintaud; Matthias Büchler; Yvon Lebranchu; Elisabeth Autret-Leca; France Mentré; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 2.  Methods for clinical monitoring of cyclosporin in transplant patients.

Authors:  R J Dumont; M H Ensom
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

3.  A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin.

Authors:  L Claret; A Iliadis; P Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

4.  Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose?

Authors:  So Won Kim; Dong Jin Kim; Dae Young Zang; Dong-Hwan Lee
Journal:  Pharmaceuticals (Basel)       Date:  2020-09-16

5.  Prediction of mutations engineered by randomness in H5N1 neuraminidases from influenza A virus.

Authors:  G Wu; S Yan
Journal:  Amino Acids       Date:  2007-08-28       Impact factor: 3.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.